Close
Enter your search into one or more of the boxes below:
You can refine your search by selecting from any of the options below:
Search
Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies
Foyalty 379

Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Hardback)

£125.00
Usually despatched within 2 weeks.

Synopsis

In recent years, a tremendous amount of effort has been focused on better understanding the fundamentals of Alzheimer's disease (AD) to facilitate early and accurate diagnosis and appropriately targeted therapeutic treatments. Alzheimer's Disease: Targets for New Clinical, Diagnostic, and Therapeutic Strategies provides a detailed synopsis of the current state of the art of diagnostics and therapeutics and identifies emerging technologies and molecules that show promise in the management and treatment of AD.











With contributions from experts drawn from academia, clinical practice, and the biotechnology and pharmaceutical industries, the book explores:























The basis of AD and the role of Ass oligomers in development of disease

Existing and emerging in vitro biomarker-based methodologies for the diagnosis of AD, focusing on genetic, biochemical, and conformational strategies

In vivo imaging diagnostic approaches

Evolving diagnostic criteria, health regulatory guidelines, biomarkers in clinical trials, and available and emerging therapies

Recent progress in small-molecule disease-modifier drug discovery efforts for AD, specifically in the areas of Ass, tau, and emerging neuroprotective/neurorepair approaches

How a case study of AD raises issues regarding clinical and pathologic criteria, risk factors, and the amyloid hypothesis

The molecular conformational factors that govern the pathogenicity of aggregating proteins, and how these factors could represent new targets for disease-modifying therapies

The latest epidemiological, pathological, biochemical, and behavioral studies that may shed some light on the risk of developing AD and similar dementias after traumatic brain injury

















Examining current hypotheses and suggesting possible new approaches to therapeutic clinical applications, this volume paves the way for a robust pipeline of therapeutics to combat not only AD, but a whole host of other neurodegenerative diseases.

Medical & VeterinaryBrances of medicineNeurology & clinical neurophysiology Publisher: Taylor & Francis Inc Publication Date: 03/05/2012 ISBN-13: 9781439827086  Details: Type: Hardback Format: Books
Availability: Usually despatched within 2 weeks. Login for Quick Checkout Add to Basket

Renee D. Wegrzyn obtained her PhD in applied biology from the Georgia Institute of Technology where she studied the propagation of prion proteins in model systems. Dr. Wegrzyn was awarded an Alexander von Humboldt Research Fellowship for her postdoctoral studies to investigate de novo protein folding at the ribosome. She applied her expertise in protein folding to the challenge of developing in vitro diagnostics for neurodegenerative diseases-including Alzheimer's and prion diseases-as a group leader at Adlyfe, Inc. She is currently a scientific and technical consultant for the Department of Defense. Alan S. Rudolph is currently a member of the senior executive service and director of Biological and Chemical Technologies for the Defense Threat Reduction Agency. He was previously chief executive officer at Adlyfe Inc., an amyloid diagnostic and biomarker company, chief of Biological Sciences at the Defense Advanced Research Projects Agency, and director of Research at the Naval Research Laboratory. He has over 90 publications in diverse areas in biophysics of cryobiology and anhydrobiosis, lipid and protein self-assembly, liposome science and technology, and tissue and cellular engineering. He has a PhD in zoology from the University of California at Davis and an MBA from the George Washington University.

More books by Renee D. Wegrzyn

More books by Alan S. Rudolph

Leave Review

Delivery

Delivery Options

All delivery times quoted are the average, and cannot be guaranteed. These should be added to the availability message time, to determine when the goods will arrive. During checkout we will give you a cumulative estimated date for delivery.

Location 1st Book Each additional book Average Delivery Time
UK Standard Delivery FREE FREE 3-5 Days
UK First Class £4.50 £1.00 1-2 Days
UK Courier £7.00 £1.00 1-2 Days
Western Europe** Courier £17.00 £3.00 2-3 Days
Western Europe** Airmail £5.00 £1.50 4-14 Days
USA / Canada Courier £20.00 £3.00 2-4 Days
USA / Canada Airmail £7.00 £3.00 4-14 Days
Rest of World Courier £22.50 £3.00 3-6 Days
Rest of World Airmail £8.00 £3.00 7-21 Days

** Includes Austria, Belgium, Denmark, France, Germany, Greece, Iceland, Irish Republic, Italy, Luxembourg, Netherlands, Portugal, Spain, Sweden and Switzerland.

Delivery Help & FAQs

Returns Information

If you are not completely satisfied with your purchase*, you may return it to us in its original condition with in 30 days of receiving your delivery or collection notification email for a refund. Except for damaged items or delivery issues the cost of return postage is borne by the buyer. Your statutory rights are not affected.

* For Exclusions and terms on damaged or delivery issues see Returns Help & FAQs

You might also like

Autism in Heels: The Untold Story of ...
(Hardback)
Jennifer O'Toole
 
 
£17.99
 
Concussion and Traumatic...
(Hardback)
Jeff Victoroff; Erin D. Bigler
 
 
£135.00
 
Thermoregulation Part II: From Basic...
(Hardback)
Andrej A. Romanovsky
 
 
£220.00
 
How to End the Autism Epidemic:...
(Paperback)
J.B. Handley
 
 
£14.99
 
© W&G Foyle Ltd
Foyles uses cookies to help ensure your experience on our site is the best possible. Click here if you’d like to find out more about the types of cookies we use.
Accept and Close